When prescribing GLP-1 receptor agonists, healthcare providers should consider the individual patients cancer risk profile and closely monitor for any signs of colorectal cancer
Learn more in our company announcement here: novonordisk.com/content/nncorp A daily GLP-1 pill could be a real access shift in Europe, especially for people who avoid injections
Its especially beneficial during illness, stress, or times of low energy and weakened immunity
This pharmacokinetic advantage means once-daily dosing provides near-continuous TREK-1 channel blockade
And, DeCaro says, weight loss itself almost never addresses the underlying psychology of the food-related disorders she treats, which are complex diseases involving emotional, relational, and biological drivers
its UK use is currently restricted to clinical trial settings